APT Medical Inc
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. The company offers electrophysiology products, such as mapping, ablation, and navigated catheter, as well as steerable, and transseptal needle and sheet; and interventional cardiology and peripheral products, including access, diagnostic, therapeutic, and acces… Read more
APT Medical Inc (688617) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.077x
Based on the latest financial reports, APT Medical Inc (688617) has a cash flow conversion efficiency ratio of 0.077x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥233.16 Million) by net assets (CN¥3.04 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
APT Medical Inc - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how APT Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
APT Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of APT Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
K&S AG
OTCQX:KPLUF
|
0.038x |
|
TBC Bank Group PLC
PINK:TBCCF
|
0.003x |
|
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329
|
0.012x |
|
Telix Pharmaceuticals Limited
PINK:TLPPF
|
0.064x |
|
Turkiye Sise ve Cam Fabrikalari AS
OTCGREY:TKKYY
|
0.040x |
|
Catena AB
ST:CATE
|
0.021x |
|
Hercules Capital Inc
NYSE:HTGC
|
0.036x |
|
SmartSens Technology (Shanghai) Co. Ltd. A
SHG:688213
|
N/A |
Annual Cash Flow Conversion Efficiency for APT Medical Inc (2017–2024)
The table below shows the annual cash flow conversion efficiency of APT Medical Inc from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.55 Billion | CN¥743.39 Million | 0.291x | -17.15% |
| 2023-12-31 | CN¥1.96 Billion | CN¥689.06 Million | 0.351x | +71.18% |
| 2022-12-31 | CN¥1.79 Billion | CN¥367.46 Million | 0.205x | +102.58% |
| 2021-12-31 | CN¥1.79 Billion | CN¥181.39 Million | 0.101x | -69.25% |
| 2020-12-31 | CN¥450.09 Million | CN¥148.24 Million | 0.329x | +107.52% |
| 2019-12-31 | CN¥345.90 Million | CN¥54.90 Million | 0.159x | +130.60% |
| 2018-12-31 | CN¥270.70 Million | CN¥18.63 Million | 0.069x | +14.29% |
| 2017-12-31 | CN¥214.43 Million | CN¥12.91 Million | 0.060x | -- |